Literature DB >> 25512821

Radiofrequency-treated recurrence of urothelial carcinoma of the upper urinary tract after nephroureterectomy.

Roberto Molina1, Manuel Alvarez1, Jesús Capilla2, Alvaro Páez1.   

Abstract

Local recurrence after radical nephroureterectomy (RNU) owing to urothelial carcinoma of the upper urinary tract is rare. The usual treatment is systemic chemotherapy followed by optional resection of the mass. We introduce the case of a 73-year-old male patient with multiple comorbidities in whom retroperitoneal carcinoma recurrence of 31 mm was diagnosed via positron emission tomography-computed tomography scan with 18-fluorodeoxyglucose about 5 years after he had undergone RNU owing to urothelial carcinoma of the upper urinary tract. The patient was treated with computed tomography-guided percutaneous radiofrequency ablation. Later scans with contrast controls showed lack of contrast uptake and a decrease of the lesion's size. Twenty-four months after the procedure, the patient is free of the disease. To date, this is the first case of recurrence of urothelial carcinoma that was treated with percutaneous radiofrequency ablation, thus establishing an alternative to chemotherapy in patients with substantial comorbidities.

Entities:  

Keywords:  Local neoplasm recurrence; Radiofrequency catheter ablation; Transitional cell carcinoma

Mesh:

Year:  2014        PMID: 25512821      PMCID: PMC4265721          DOI: 10.4111/kju.2014.55.12.844

Source DB:  PubMed          Journal:  Korean J Urol        ISSN: 2005-6737


  10 in total

Review 1.  Laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: is it better than open surgery?

Authors:  Jens J Rassweiler; Michael Schulze; Reinaldo Marrero; Thomas Frede; Juan Palou Redorta; Pierfrancesco Bassi
Journal:  Eur Urol       Date:  2004-12       Impact factor: 20.096

2.  Long-term outcomes after percutaneous radiofrequency ablation for renal cell carcinoma.

Authors:  Ronald J Zagoria; Joseph A Pettus; Morgan Rogers; David M Werle; David Childs; John R Leyendecker
Journal:  Urology       Date:  2011-04-13       Impact factor: 2.649

3.  Impact of multimodal treatment on survival in patients with metastatic urothelial cancer.

Authors:  Takashige Abe; Nobuo Shinohara; Toru Harabayashi; Ataru Sazawa; Satoru Maruyama; Shin Suzuki; Katsuya Nonomura
Journal:  Eur Urol       Date:  2007-03-06       Impact factor: 20.096

4.  A population-based assessment of perioperative mortality after nephroureterectomy for upper-tract urothelial carcinoma.

Authors:  Claudio Jeldres; Maxine Sun; Hendrik Isbarn; Giovanni Lughezzani; Lars Budäus; Ahmed Alasker; Shahrohk F Shariat; Jean-Baptiste Lattouf; Hugues Widmer; Daniel Pharand; Philippe Arjane; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Journal:  Urology       Date:  2009-12-06       Impact factor: 2.649

5.  Upper urinary tract urothelial carcinoma: what have we learned in the last 4 years?

Authors:  Mesut Remzi; Shahrokh Shariat; Wilhelm Huebner; Harun Fajkovic; Christian Seitz
Journal:  Ther Adv Urol       Date:  2011-04

6.  Laparoscopic nephroureterectomy for transitional cell carcinoma of renal pelvis and ureter: Nagoya experience.

Authors:  Ryohei Hattori; Yasushi Yoshino; Momokazu Gotoh; Masashi Katoh; Osamu Kamihira; Yoshinari Ono
Journal:  Urology       Date:  2006-03-29       Impact factor: 2.649

7.  Early results of chemotherapy with retroperitoneal lymph node dissection for isolated retroperitoneal recurrence of upper urinary tract urothelial carcinoma after nephroureterectomy.

Authors:  M Adam Childs; Christopher G Wood; Philippe E Spiess; Labib G Debiane; Mike Hernandez; Surena F Matin; Randall E Millikan; Arlene Siefker-Radtkie; Shellie M Scott; Louis L Pisters
Journal:  Can J Urol       Date:  2010-06       Impact factor: 1.344

8.  Surgery for metastatic urothelial carcinoma with curative intent: the German experience (AUO AB 30/05).

Authors:  Jan Lehmann; Henrik Suttmann; Peter Albers; Björn Volkmer; Jürgen E Gschwend; Guido Fechner; Martin Spahn; Axel Heidenreich; Axel Odenthal; Christoph Seif; Nils Nürnberg; Christian Wülfing; Christoph Greb; Tilmann Kälble; Marc-Oliver Grimm; Claus Friedrich Fieseler; Susanne Krege; Margitta Retz; Heiner Schulte-Baukloh; Martin Gerber; Markus Hack; Jörn Kamradt; Michael Stöckle
Journal:  Eur Urol       Date:  2008-11-29       Impact factor: 20.096

9.  Is there a therapeutic role for post-chemotherapy retroperitoneal lymph node dissection in metastatic transitional cell carcinoma of the bladder?

Authors:  Paul Sweeney; Randall Millikan; Machelle Donat; Christopher G Wood; Arlene Siefker Radtke; Curtis A Pettaway; H Barton Grossman; Colin P N Dinney; David A Swanson; Louis L Pisters
Journal:  J Urol       Date:  2003-06       Impact factor: 7.450

10.  Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients.

Authors:  M C Hall; S Womack; A I Sagalowsky; T Carmody; M D Erickstad; C G Roehrborn
Journal:  Urology       Date:  1998-10       Impact factor: 2.649

  10 in total
  1 in total

1.  Percutaneous laser ablation: a new contribution to unresectable high-risk metastatic retroperitoneal lesions?

Authors:  Tian'an Jiang; Zhuang Deng; Guo Tian; Fen Chen; Haiwei Bao; Ju Li; Weilin Wang
Journal:  Oncotarget       Date:  2017-01-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.